Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects
File version
Accepted Manuscript (AM)
Author(s)
Esposito, M
Grusovin, MG
Papanikolaou, N
Coulthard, P
Worthington, HV
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
P. Mark Bartold
Date
Size
File type(s)
Location
License
Abstract
Background: Periodontitis is a chronic infective disease of the gums caused by bacteria present in dental plaque. This condition induces the breakdown of the tooth supporting apparatus until teeth are lost. Surgery may be indicated to arrest disease progression and regenerate lost tissues. Several surgical techniques have been developed to regenerate periodontal tissues including guided tissue regeneration (GTR), bone grafting (BG) and the use of enamel matrix derivative (EMD). EMD is an extract of enamel matrix and contains amelogenins of various molecular weights. Amelogenins are involved in the formation of enamel and periodontal attachment formation during tooth development. Objectives: To test whether EMD is effective, and to compare EMD versus GTR, and various BG procedures for the treatment of intrabony defects.
Journal Title
Conference Title
Book Title
Edition
Volume
55
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Author Posting. © 2010 Australian Dental Association. This is the peer reviewed version of the following article: Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects, Australian Dental Journal, Volume 55, Issue 1, March 2010, Pages 101-104, which has been published in final form at https://doi.org/10.1111/j.1834-7819.2009.01186.x. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Dentistry
Periodontics